drugset / Trial / NCT07021430
Focal Mass Drug Administration for the Prevention of Malaria in Pregnancy
Phase 0
Not yet recruiting
300 enrolled
University of North Carolina, Chapel Hill
National Institute of Allergy and Infectious Diseases (NIAID) · collab
RandomizedFactorialOpen-labelPrevention
Summary
The purpose of this study is to demonstrate the feasibility, acceptability, and preliminary effectiveness of a focal mass drug administration program for household members of pregnant women to protect against malaria in pregnancy.
Timeline
- Start
- 2026-07
- Primary completion
- 2028-07
- Completion
- 2028-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dihydroartemisinin-piperaquine | Unknown | — | Oral |